Literature DB >> 23801161

[Non-invasive and invasive urothelial tumours: special challenges in uropathological diagnostics].

N T Gaisa1, K Lindemann-Docter.   

Abstract

The current 2004 WHO classification of bladder tumors categorizes non-invasive and invasive urothelial neoplasms into prognostically relevant groups according to the histopathological cell morphology and underlying genetic changes. Although many parts of the classification have not been changed dramatically, even small changes have caused uncertainty and scepticism among urologists and pathologists in recent years. The following review article is structured into various challenges for urologists and pathologists and provides an overview of rare but clinically relevant subgroups and diagnostics, interpretation of diagnoses and pathological findings with respect to consequences for the daily clinical routine (extended diagnosis, therapy and prognosis).

Entities:  

Mesh:

Year:  2013        PMID: 23801161     DOI: 10.1007/s00120-013-3225-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  25 in total

1.  Constructing prognostic model incorporating the 2004 WHO/ISUP classification for patients with non-muscle-invasive urothelial tumours of the urinary bladder.

Authors:  Chin-Chen Pan; Yen-Hwa Chang; Kuang-Kuo Chen; Hui-Jung Yu; Chih-Hao Sun; Donald M T Ho
Journal:  J Clin Pathol       Date:  2010-10       Impact factor: 3.411

Review 2.  Clinical and therapeutic significance of aberrant differentiation patterns in bladder cancer.

Authors:  Peter C Black; Gordon A Brown; Colin P N Dinney
Journal:  Expert Rev Anticancer Ther       Date:  2007-07       Impact factor: 4.512

3.  Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry.

Authors:  Antonio Lopez-Beltran; Maria J Requena; Jose Alvarez-Kindelan; Ana Quintero; Ana Blanca; Rodolfo Montironi
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

4.  Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital.

Authors:  Rajal B Shah; Jeffrey S Montgomery; James E Montie; Lakshmi P Kunju
Journal:  Urol Oncol       Date:  2012-05-17       Impact factor: 3.498

Review 5.  The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer.

Authors:  Wolfgang Otto; Stefan Denzinger; Hans-Martin Fritsche; Maximilian Burger; Wolf F Wieland; Ferdinand Hofstädter; Arndt Hartmann; Simone Bertz
Journal:  BJU Int       Date:  2010-08-12       Impact factor: 5.588

Review 6.  Glandular lesions of the urinary bladder:clinical significance and differential diagnosis.

Authors:  Sean R Williamson; Antonio Lopez-Beltran; Rodolfo Montironi; Liang Cheng
Journal:  Histopathology       Date:  2010-09-21       Impact factor: 5.087

7.  Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.

Authors:  M-T Sung; M Wang; G T MacLennan; J N Eble; P-H Tan; A Lopez-Beltran; R Montironi; J J Harris; M Kuhar; L Cheng
Journal:  J Pathol       Date:  2007-03       Impact factor: 7.996

8.  Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy.

Authors:  Adrian S Fairey; Siamak Daneshmand; Lina Wang; Anne Schuckman; Gary Lieskovsky; Hooman Djaladat; Jie Cai; Gus Miranda; Eila C Skinner
Journal:  Urol Oncol       Date:  2013-03-14       Impact factor: 3.498

9.  Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer.

Authors:  Venu Chalasani; Joseph L Chin; Jonathan I Izawa
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

10.  Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update.

Authors:  C J Logothetis; D E Johnson; C Chong; F H Dexeus; A Sella; S Ogden; T Smith; D A Swanson; R J Babaian; K I Wishnow
Journal:  J Clin Oncol       Date:  1988-10       Impact factor: 44.544

View more
  1 in total

Review 1.  [Cytology in uropathological diagnostics].

Authors:  N T Gaisa; K Lindemann-Docter
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.